Whitehawk Therapeutics, Inc. - Common stock (WHWK)

Q2 2025 13F Holders as of 6/30/2025

Type / Class
Equity / Common stock
Shares outstanding
47.1M
Number of holders
38
Total 13F shares, excl. options
29.4M
Shares change
-487K
Total reported value, excl. options
$54.6M
Value change
-$892K
Number of buys
11
Number of sells
-22
Price
$1.87

Significant Holders of Whitehawk Therapeutics, Inc. - Common stock (WHWK) as of Q2 2025

51 filings reported holding WHWK - Whitehawk Therapeutics, Inc. - Common stock as of Q2 2025.
Whitehawk Therapeutics, Inc. - Common stock (WHWK) has 38 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 29.4M shares of 47.1M outstanding shares and own 62.43% of the company stock.
Largest 10 shareholders include QVT Financial LP (4.62M shares), ORBIMED ADVISORS LLC (4.17M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (3.7M shares), ACUTA CAPITAL PARTNERS, LLC (3.41M shares), Avoro Capital Advisors LLC (2.85M shares), Siren, L.L.C. (2.08M shares), Yu Fan (2.07M shares), VANGUARD GROUP INC (1.32M shares), ACORN CAPITAL ADVISORS, LLC (1.14M shares), and EcoR1 Capital, LLC (1.09M shares).
This table shows the top 38 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.